ALS Beauty, recently integrated into ALS Global, represents a strategic synergy in the biotechnology, healthcare, and pharmaceutical sectors. Founded in 1985, the company has evolved into a notable player within these industries through its subsidiary, BioScreen Testing Services.
BioScreen Testing Services operates as a full-service analytical chemistry and microbiology contract laboratory. The company is committed to excellence, offering superior customer service, quality, and regulatory compliance. This dedication to ongoing improvement underscores the principles reflected in their operations and customer outcomes.
Headquartered in the United States, ALS Beauty does not list recent investments or specific investor participation. The firm’s integration into ALS Global positions it advantageously within the market for potential growth and innovation. Investors should consider this a firm grounded in quality and integrity, poised for strategic collaborations and sector expansion.